GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Global Longlife Hospital and Research Ltd

Global Longlife Hospital Board Approves Name Change and Business Diversification

RESULTS ▼ Concern Flagged HIGH RISK
📅 Filed on BSE: 07 May 2026, 03:48 PM IST  ·  BSE ID: 449ce895-8334-4a46-903c-944839f2d9b2
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board approved its financial results and plans to change its name and shift its main business from hospitals to trade and services.
🤖 AI Summary
  • - Board approved Audited Financial Results for Half Year and Year ended March 31, 2026.
  • - Proposal to alter company name to Kanzi Enterprise Limited or Asahi Enterprise Limited or Siddhaa Enterprise Limited.
  • - Proposed alteration of Main Object Clause from healthcare to trade and service industry.
  • - Both name and object clause changes are subject to shareholder and MCA approvals.
  • - Statutory Auditors issued an unmodified opinion on the financial results for FY26.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Net Profit/(Loss) from continuing activities after tax (Year Ended March 31, 2026)
(Rs. 171.95) Lakhs
Not comparable — limited prior period data.
Net Profit/(Loss) from continuing activities after tax (Year Ended March 31, 2025)
Rs. 19.87 Lakhs
Revenue from Operations (Year Ended March 31, 2026)
Rs. 0.00 Lakhs
Not comparable — limited prior period data.
Revenue from Operations (Year Ended March 31, 2025)
Rs. 57.73 Lakhs
Total Income (Year Ended March 31, 2026)
Rs. 0.52 Lakhs
Not comparable — limited prior period data.
Total Income (Year Ended March 31, 2025)
Rs. 559.34 Lakhs
🏢 How This Affects the Company
📈
Business Impact
The proposed alteration of the Main Object Clause signifies a fundamental shift away from the healthcare industry into the trade and service industry, fundamentally changing its core operations. This redefines the company's market and service offerings. Revenue from Operations for the year ended March 31, 2026, was - Rs. 0.00 Lakhs, indicating no operational revenue from its existing healthcare business.
💰
Financial Impact
The company reported a Net Loss after tax of (Rs. 171.95) Lakhs for the year ended March 31, 2026, widening from a Net Profit of Rs. 19.87 Lakhs in the prior year. Total Income for the year ended March 31, 2026, was Rs. 0.52 Lakhs, a significant reduction from Rs. 559.34 Lakhs in the previous year. Expenses amounted to Rs. 99.32 Lakhs for the year ended March 31, 2026, down from Rs. 549.42 Lakhs.
⚙️
Operational Impact
The proposed shift in the Main Object Clause from healthcare to trade and service industry will require a complete restructuring of the company's operational model, including workforce, asset utilization, and supply chain. This transition is subject to approvals and will require new operational strategies.
⚠️
Risk Impact
The proposed business model change introduces new operational and market risks associated with entering the trade and service industry, where the company may lack established expertise. Significant losses for the year ended March 31, 2026, indicate current business challenges that necessitate this strategic pivot. This change, if approved, alters the fundamental risk profile of the company.
👥 What This Means For Shareholders
✅
Action Required
Shareholders will need to vote on the proposed alteration of the company's name and the change in its Main Object Clause during an upcoming meeting.
👤
Who Is Affected
All shareholders are affected as the proposed changes redefine the company's identity and core business, moving it from the healthcare industry to the trade and service industry. Existing shareholding structure remains unchanged by this specific disclosure.
🔍
Management Signal
The Board's decision signals an intent to strategically reorient the company's business focus away from healthcare towards the trade and service sector, possibly in response to current operational and financial performance.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Shareholder meeting results for name and object clause alteration approvals.
Ministry of Corporate Affairs approval for company name and object clause changes.
Future filings detailing new business strategy and operational plans for trade and service.
HIGH RISK Zero operational revenue and significant losses for FY26, combined with a major business model change, introduce high risk.
💡 Investor Takeaway
The company reported a Net Loss after tax of (Rs. 171.95) Lakhs for the year ended March 31, 2026, with Revenue from Operations at Rs. 0.00 Lakhs. The Board approved fundamental changes including name alteration and a shift in main object clause from healthcare to the trade and service industry, pending shareholder and MCA approvals.
⚖️ Strengths & Concerns

✅ Positives

  • Statutory Auditors issued an unmodified opinion on the Audited Financial Results for the year ended March 31, 2026, indicating sound financial reporting practices.
  • The company demonstrated a reduction in total expenses to Rs. 99.32 Lakhs for the year ended March 31, 2026, from Rs. 549.42 Lakhs in the prior year.

⚠️ Concerns

  • Global Longlife Hospital and Research Limited reported a Net Loss after tax of (Rs. 171.95) Lakhs for the year ended March 31, 2026, compared to a Net Profit of Rs. 19.87 Lakhs YoY.
  • Revenue from Operations for the year ended March 31, 2026, was Rs. 0.00 Lakhs, a substantial decline from Rs. 57.73 Lakhs in the previous year.
📅 Company Track Record
Global Longlife Hospital and Research Limited was incorporated on July 10, 2012 (CIN: L85110GJ2012PLC068700). There are no previous financial filings context provided beyond the current disclosure.

Based on publicly available historical data. For context only.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.